Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-29 08:29:01 Page View：399

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Obesity drug from Roche shows promise in early study
Next article： Psychedelics group wrestles with new pharma identity

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Study suggests new cause of Down syndrome: cells linked to aging

NeuralprogenitorcellsderivedfromstemcellsofapersonwithDownsyndrome.CourtesyHiruyMeharenaDownsyndrome

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Lilly’s weekly insulin works as well as daily products, new studies show

AdobeEliLillyreportedThursdaythatitsexperimentalweeklyinsulinworkedaswellasdailybasalinsulinproducts